Search Results - "Fangous, M.S."
-
1
Lactobacilli intra-tracheal administration protects from Pseudomonas aeruginosa pulmonary infection in mice - a proof of concept
Published in Beneficial microbes (09-12-2019)“…The spreading of antibiotic resistance is a major public health issue, which requires alternative treatments to antibiotics. Lactobacilli have shown abilities…”
Get more information
Journal Article -
2
Elizabethkingia anophelis outbreak in France
Published in Infectious diseases now (Online) (01-08-2022)“…•Elizabethkingia anophelis was responsible for a high mortality rate outbreak.•A common environmental reservoir was suspected.•Treatment can be difficult and…”
Get full text
Journal Article -
3
The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study
Published in Infectious diseases now (Online) (01-08-2022)“…•The main risk factors for vaccine failure were anti-CD20 therapy.•Other risk factors for vaccine failure were hypogammaglobulinemia and lymphopenia.•mRNA…”
Get full text
Journal Article -
4
QuantiFERON et Liaison XL : retour d’expérience sur les tests indéterminés
Published in Médecine et maladies infectieuses (01-09-2020)“…Le diagnostic d’infection tuberculeuse latente (ITL) repose sur des tests immunologiques détectant la réponse T mémoire dirigée contre Mycobacterium…”
Get full text
Journal Article -
5
Et si ce n’était pas un cancer ? À propos de 13 cas de tularémie pulmonaire
Published in Médecine et maladies infectieuses (01-09-2020)“…La tularémie est une infection due à Francisella tularensis, un coccobacille à Gram négatif intracellulaire. La forme ulcéro-ganglionnaire est la plus décrite,…”
Get full text
Journal Article -
6
Abcès pulmonaire à Gallibacterium anatis
Published in Médecine et maladies infectieuses (01-02-2017)Get full text
Journal Article -
7
L’administration intranasale de Lactobacillus : un moyen efficace de protéger des infections pulmonaires à P. aeruginosa ?
Published in Médecine et maladies infectieuses (01-06-2018)“…Pseudomonas aeruginosa est responsable d’infections respiratoires, notamment chez le patient atteint de mucoviscidose (CF). L’acquisition progressive de…”
Get full text
Journal Article